Immunogenicity of hepatitis a vaccine in children with celiac disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 53, Issue 5, 2011, Pages 532-535

  Sari, Sinan ^a   Dalgic, Buket ^a   Basturk, Bilkay ^b   Gonen, Sevim ^c   Soylemezoglu, Oguz ^c  

^a GAZI UNIVERSITY   (Turkey)

^b Department of Immunology ^*  (Turkey)

^c GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Celiac disease; Hepatitis A vaccine; Immunization

Indexed keywords

HEPATITIS A ANTIGEN; HEPATITIS A VACCINE; HLA ANTIGEN; HLA DQ ANTIGEN; HLA DQ2 ANTIGEN; HLA DQ3 ANTIGEN; HLA DQ6 ANTIGEN; HLA DR11 ANTIGEN; HLA DR14 ANTIGEN; HLA DR3 ANTIGEN; HLA DR7 ANTIGEN; INACTIVATED VIRUS VACCINE; UNCLASSIFIED DRUG;

ALLELE; ANTIBODY TITER; ARTICLE; CELIAC DISEASE; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS A VIRUS; HUMAN; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; SEROCONVERSION;

ALLELES; CASE-CONTROL STUDIES; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HEPATITIS A VIRUS, HUMAN; HLA ANTIGENS; HUMANS; MALE; VACCINES, INACTIVATED;

HEPATITIS A VIRUS;

EID: 80255131413     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318223b3ed     Document Type: Article

References (36)

1. Yeung LT, Roberts EA. Current issues in the management of paediatric viral hepatitis. Liver Int 2010;30:5-18.
2. Fiore AE,Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006;55:1-23.
3. Craig AS, Schaffner W. Prevention of hepatitis A with the hepatitis A vaccine. N Engl J Med 2004;350:476-81. (Pubitemid 38133768)
4. Bian GL, Ma R, Dong HJ, et al. Long-term clinical observation of the immunogenicity of inactivated hepatitis A vaccine in children. Vaccine 2010;28:4798-801.
5. Hepatitis A vaccines. Wkly Epidemiol Rec 2000;75:38-44.
6. Ovsyannikova IG, Dhiman N, Jacobson RM, et al. Human leukocyte antigen polymorphisms: variable humoral immune responses to viral vaccines. Exp Rev Vaccines 2006;5:33-43.
7. King AL, Ciclitira PJ. Celiac disease: strongly heritable, oligogenic, but genetically complex. Mol Genet Metab 2000;71:70-5.
8. Plenge RM. Unlocking the pathogenesis of celiac disease. Nat Genet 2010;42:281-2.
9. Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 1993;105: 910-22. (Pubitemid 23249504)
10. Ertem D, Gonen I, Tanidir C, et al. The response to hepatitis B vaccine: does it differ in celiac disease? Eur J Gastroenterol Hepatol 2010;22: 787-93.
11. Park SD, Markowitz J, Pettei M, et al. Failure to respond to hepatitis B vaccine in children with celiac disease. J Pediatr Gastroenterol Nutr 2007;44:431-5. (Pubitemid 46573225)
12. Noh KW, Poland GA, Murray JA. Hepatitis B vaccine nonresponse and celiac disease. Am J Gastroenterol 2003;98:2289-92. (Pubitemid 37305372)
13. Nemes E, Lefler E, Szegedi L, et al. Gluten intake interferes with the humoral immune response to recombinant hepatitis B vaccine in patients with celiac disease. Pediatrics 2008;121:e1570-6.
14. Leonardi S, Spina M, Spicuzza L, et al. Hepatitis B vaccination failure in celiac disease: is there a need to reassess current immunization strategies? Vaccine 2009;27:6030-3.
15. Ahishali E, Boztas G, Akyuz F, et al. Response to hepatitis B vaccination in patients with celiac disease. Dig Dis Sci 2008;53:2156-9.
16. Radzikowski A, Banaszkiewicz A, Lazowska-Przeorek I, et al. Immunogenecity of hepatitis A vaccine in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 2010;17:1117-24.
17. Ferreira CT, Leite JC, Taniguchi A, et al. Immunogenicity and safety of an inactivated hepatitis A vaccine in children with Down syndrome. J Pediatr Gastroenterol Nutr 2004;39:337-40.
18. Keeffe EB, Iwarson S, McMahon BJ, et al. Safety and immunogenicity of hepatitis Avaccine in patients with chronic liver disease. Hepatology 1998;27:881-6. (Pubitemid 28103570)
19. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 1992;102:330-54.
20. Karakayali H, Ekici Y, Ozcay F, et al. Pediatric liver transplantation for acute liver failure. Transplant Proc 2007;39:1157-60. (Pubitemid 46764849)
21. Kurugol Z, Mutlubas F, Ozacar T. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years. Vaccine 2005;23:2876-80. (Pubitemid 40386489)
22. Lopez EL, Contrini MM, Xifro MC, et al. Hepatitis A vaccination of Argentinean infants: comparison of two vaccination schedules. Vaccine 2007;25:102-8. (Pubitemid 44855241)
23. Werzberger A, Mensch B, Kuter B, et al. A controlled trial of a formalininactivated hepatitis A vaccine in healthy children. N Engl J Med 1992;327:453-7.
24. Bell BP, Negus S, Fiore AE, et al. Immunogenicity of an inactivated hepatitis A vaccine in infants and young children. Pediatr Infect Dis J 2007;26:116-22. (Pubitemid 46183360)
25. Marshall H, Nolan T, Diez Domingo J, et al. Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 years. Vaccine 2010;28:4411-5.
26. Koksal Y, Yalcin B, Aydin GB, et al. Immunogenicity of hepatitis A vaccine in children with cancer. Pediatr Hematol Oncol 2006;23:619-24. (Pubitemid 44653058)
27. Ferreira CT, da Silveira TR, Vieira SM, et al. Immunogenicity and safety of hepatitis A vaccine in children with chronic liver disease. J Pediatr Gastroenterol Nutr 2003;37:258-61. (Pubitemid 39274514)
28. Arguedas MR, Johnson A, Eloubeidi MA, et al. Immunogenicity of hepatitis Avaccination in decompensated cirrhotic patients. Hepatology 2001;34:28-31. (Pubitemid 32591479)
29. Arslan M, Wiesner RH, Poterucha JJ, et al. Safety and efficacy of hepatitis A vaccination in liver transplantation recipients. Transplantation 2001;72:272-6. (Pubitemid 32729348)
30. VanLoveren H,VanAmsterdamJG,Vandebriel RJ, et al.Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors. Environ Health Perspect 2001;109:757-64. (Pubitemid 32910296)
31. Hohler T, Reuss E, Evers N, et al. Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins. Lancet 2002;360:991-5. (Pubitemid 35284111)
32. Launay O, Grabar S, Gordien E, et al. Immunological efficacy of a threedose schedule of hepatitis Avaccine in HIV-infected adults: HEPAVAC study. J Acquir Immune Defic Syndr 2008;49:272-5.
33. Reuman PD, Kubilis P, Hurni W, et al. The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults. Vaccine 1997;15:1157-61. (Pubitemid 27357202)
34. Ozgenc F, Aksu G, Kirkpinar F, et al. The influence of marginal zinc deficient diet on post-vaccination immune response against hepatitis B in rats. Hepatol Res 2006;35:26-30.
35. Letson GW, Shapiro CN, Kuehn D, et al. Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants. J Pediatr 2004;144:327-32. (Pubitemid 38333889)
36. Orr N, Klement E, Gillis D, et al. Long-term immunity in young adults after a single dose of inactivated hepatitis A vaccines. Vaccine 2006;24:4328-32.